Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control
- PMID: 25974081
- PMCID: PMC4431881
- DOI: 10.1371/journal.pntd.0003507
Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Merck & Co Inc. (1987) Fact sheet—Merck Mectizan Donation Program—river blindness (onchocerciasis). MCT-2007-PA-003-BK. http://www.mectizan.org/resources/merck-fact-sheet-2007 Accessed: August 6, 2014.
-
- Sturchio JL, Colatrella BD. (2002) 14 successful public-private partnerships in global health: lessons from the Mectizan Donation Program In: Granville B, editor. The Economics of Essential Medicines. London: Royal Institute of International Affairs; pp. 255–274.
-
- Dull HB. (1990) Mectizan donation and the Mectizan Expert Committee. Acta Leiden 59: 399–403. - PubMed
-
- World Health Organization. (1996) Community directed treatment with ivermectin: report of the multi-country study. TDR/AFR/RP/96.1. http://www.who.int/tdr/publications/tdr-research-publications/ivermectin... (5/22/2013).
-
- Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, et al. (2002) APOC's strategy of community-directed treatment with ivermectin (CDTi) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Ann Trop Med Parasitol 96 Suppl 1: S93–104. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
